Consumer groups fight plans for “direct to patient” drug advertisementsBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7318.889 (Published 20 October 2001) Cite this as: BMJ 2001;323:889
- Rory Watson
Some of Europe's leading consumer organisations, including the UK Consumers' Association and National Consumer Council, are opposing plans to allow limited direct advertising of prescription medicines to special patients groups.
The European Commission raised the possibility in July of relaxing the current ban on direct advertising by pharmaceutical companies when it proposed changes to existing legislation that dates from 1995 (28 July, p 184).
However, it suggested that the advertising could relate only to AIDS, diabetes, and asthma and would need to be authorised by …
Log in using your username and password
Log in through your institution
Sign up for a free trial